About BRIJ Medical
BRIJ Medical makes devices that cover, protect and take tension off surgical incisions. Brijjit is a force-modulating tissue bridge that offloads up to 100% of incisional tension. BRIJ-SEAL is a single-use, sterile wound closure device with a 14-day bacterial barrier. Surgeons can use BRIJ-SEAL alone or together with Brijjit. Brijjit is prescription-only. The company is preparing to introduce BRIJ-Ag, a silver-based antimicrobial wound dressing.
The company has an office in Marietta, Georgia, and another in Solana Beach, California. Dr. Felmont (Monte) Eaves III, a plastic surgeon, founded it, and Tim Gleeson is chief executive officer. Surgeons in orthopedic, plastic and spine surgery use its products. Premier members can buy Brijjit under a national group purchasing agreement effective December 15, 2024. BRIJ-SEAL joined with a Breakthrough Technology designation effective August 1, 2026.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Oct 23, 2026 | $5,000,000fully sold | 83 | $60,241 | Debt, Options, Convertible Promissory Notes convertible into Preferred StockRule 506(b) | Form D ↗ |
| Feb 28, 2025 | Mar 13, 2025amended Feb 26, 2026 | $1,200,000of $6.3M target | 17 | $70,588 | Options, SAFERule 506(b) | Form D/A ↗1 earlier filing |
| Dec 6, 2023 | Dec 8, 2023amended Feb 28, 2024 | $5,577,359of $5.7M target | 77 | $72,433 | Equity, Series Seed Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | Aug 31, 2023 | $0of $1.0M target | 0 | — | Debt, Common Stock, Preferred Stock and Convertible NotesRule 506(b) | Form D ↗ |
| Sep 2, 2022 | Sep 12, 2022 | $200,000of $1.5M target | 3 | $66,667 | Debt, OptionsRule 506(c) | Form D ↗ |
| Jul 15, 2021 | Jul 21, 2021 | $4,770,855of $10.0M target | 43 | $110K | EquityRule 506(c) | Form D ↗ |
| Total, six offerings | $16,748,214 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by BRIJ Medical
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Nov 3, 2026 | Financing round | $5M | The company's Board of Directors (lead), Existing investors (most of the participation) | PR Newswire release ↗ Company news post ↗ |
| Jan 8, 2026 | SAFE round (oversubscribed) | Undisclosed | Existing and new investors | Company news post ↗ |
| Feb 12, 2024 | Seed round | $5.5M | Tim Gleeson (Vidant Capital) (lead), MedTech industry veterans | Company news post ↗ |
Why Investors Backed BRIJ Medical
BRIJ Medical sells Brijjit and BRIJ-SEAL, two devices that surgeons use on surgical incisions. Brijjit takes tension off the incision, and BRIJ-SEAL covers it with a bacterial barrier. On November 3, 2026, the company announced a closed $5 million round. Its board of directors led the round, and most of the money came from existing investors.
The problem it targets
BRIJ's view is that tension on the incision and allergic reactions after surgery are two of surgery's most overlooked problems. Chief executive officer Tim Gleeson's view is that surgeons want a product that is fast, easy to apply and protects the incision. He adds that it should not cause adhesive-related skin reactions. Traditional topical skin adhesives contain cyanoacrylates, and BRIJ-SEAL does not.
What the product does
Brijjit takes the place of the final suture layer, which can be sutures, glues, staples or tapes. BRIJ puts it at up to 9x faster than suture placement. BRIJ-SEAL uses the same hypoallergenic adhesive as Brijjit, which has no reported allergic reactions across six clinical studies. It is breathable and waterproof, and patients can shower under their surgeon's guidance. In lab testing it blocked bacterial penetration by six organisms, including MRSA, VRE and P. aeruginosa. It can be applied in seconds.
Progress so far
BRIJ launched BRIJ-SEAL commercially in July 2026. In 2025 it joined the MedTech Innovator accelerator cohort, one of 65 startups chosen from nearly 1,500 applicants. It was later a finalist in the Mid-Stage Grand Prize competition. Since July 2025, VA and DoD healthcare providers can get Brijjit through the ECAT electronic catalog, via partner Red One Medical. In September 2026, a 100-case sports medicine study of Brijjit appeared in the Journal of Orthopaedic Experience & Innovation. BRIJ cites breast studies, including a randomized trial at UTSW, that reported 90% less wound breakdown and 38% less scar area.
Who backs it
The November 2026 round started with a $3 million target. BRIJ raised it to $5 million in response to investor demand. The board led it, and most participation came from existing investors. Chairman John Grotting's view is that BRIJ is at an important inflection point. Proceeds will mainly support commercial expansion and the launch of BRIJ-Ag. A SAFE round announced in January 2026 was oversubscribed. A $5.5 million seed round in February 2024 was led by Tim Gleeson of Vidant Capital, with MedTech industry veterans. Gleeson is now chief executive officer.
We wrote this summary from public statements by BRIJ Medical and its investors. It is not investment advice.
Leadership Team
Executive officers and directors listed on BRIJ Medical's Form D filed Oct 23, 2026.
Earlier filings also listed David Grant (executive officer, last listed Feb 2024), Johnna Hafner (executive officer, last listed Aug 2023), Felmont Eaves, Iii, Md (executive officer and director, last listed Aug 2023), Alistair Simpson (executive officer and director, last listed Aug 2023) and Johanna Hafner (executive officer, last listed Jul 2021).
Sources
- SECBrij Medical, Inc. Form D, filed Mar 13, 2025
- SECBrij Medical, Inc. Form D, filed Dec 8, 2023
- SECBrij Medical, Inc. filing history
- CompanyBRIJ Medical: Our BRIJ Story
- CompanyBRIJ Medical: Our Team
- CompanyBRIJ Medical: Contact Us
- CompanyBRIJ Medical: News
- CompanyBRIJ Medical launches BRIJ-SEAL (company post)
- CompanyRed One Medical ECAT listing (company post)
- PressPR Newswire: Breakthrough Technology designation for BRIJ-SEAL with Premier
- PressPR Newswire: Breakthrough Technology agreement with Premier